J M P Horgan1, A Blenkinsopp, R J McManus. 1. NHS South Birmingham, Trust Headquarters, Moseley Hall Hospital, Alcester Road, Moseley, Birmingham B13 8JL, UK. jonathan.horgan@sbpct.nhs.uk
Abstract
BACKGROUND: Cardiovascular risk-based screening is proposed as a key intervention to reduce premature cardiovascular disease (CVD) in the UK and internationally. This study evaluated a targeted cardiovascular (CVD) assessment pilot in 23 community pharmacies in Birmingham, UK. METHODS: The CVD risk assessment service used near-patient testing and the Framingham risk equations administered by pharmacists to screen clients aged 40-70 without known CVD. Outcomes assessed included volume of activity, uptake by deprivation and ethnicity and onwards referral. RESULTS: Complete data were available for 1130 of 1141 clients; 679 (60%) male, 218 (19%) smokers and 124 (11%) had a family history of CVD. Overall, 792 (70%) of clients were referred to their general practice: 201 (18%) at CVD risk of 20% or more, remainder with individual risk factor(s). Greater representation from Black (7.4%) and Asian (24.8%) communities and from average and less deprived quintiles than the affluent and most deprived was observed. CONCLUSIONS: Community pharmacies can provide a CVD risk assessment service in a UK urban setting that can attract males and provide access for deprived communities and Black and Asian communities. A pharmacy service can support GP practices in identifying and managing the workload of around 30% of clients.
BACKGROUND: Cardiovascular risk-based screening is proposed as a key intervention to reduce premature cardiovascular disease (CVD) in the UK and internationally. This study evaluated a targeted cardiovascular (CVD) assessment pilot in 23 community pharmacies in Birmingham, UK. METHODS: The CVD risk assessment service used near-patient testing and the Framingham risk equations administered by pharmacists to screen clients aged 40-70 without known CVD. Outcomes assessed included volume of activity, uptake by deprivation and ethnicity and onwards referral. RESULTS: Complete data were available for 1130 of 1141 clients; 679 (60%) male, 218 (19%) smokers and 124 (11%) had a family history of CVD. Overall, 792 (70%) of clients were referred to their general practice: 201 (18%) at CVD risk of 20% or more, remainder with individual risk factor(s). Greater representation from Black (7.4%) and Asian (24.8%) communities and from average and less deprived quintiles than the affluent and most deprived was observed. CONCLUSIONS: Community pharmacies can provide a CVD risk assessment service in a UK urban setting that can attract males and provide access for deprived communities and Black and Asian communities. A pharmacy service can support GP practices in identifying and managing the workload of around 30% of clients.
Authors: Nicole Lowres; Ines Krass; Lis Neubeck; Julie Redfern; Andrew J McLachlan; Alexandra A Bennett; S Ben Freedman Journal: Int J Clin Pharm Date: 2015-07-23
Authors: Hadi A Almansour; Nouf M Aloudah; Tariq M Alhawassi; Betty Chaar; Ines Krass; Bandana Saini Journal: Explor Res Clin Soc Pharm Date: 2021-09-29
Authors: Kevin P Mc Namara; Johnson George; Sharleen L O'Reilly; Shane L Jackson; Gregory M Peterson; Helen Howarth; Michael J Bailey; Gregory Duncan; Peta Trinder; Elizabeth Morabito; Jill Finch; Stephen Bunker; Edward Janus; Jon Emery; James A Dunbar Journal: BMC Health Serv Res Date: 2010-09-07 Impact factor: 2.655
Authors: Rebekah J McNaughton; Nigel T A Oswald; Janet S Shucksmith; Peter J Heywood; Pat S Watson Journal: BMC Health Serv Res Date: 2011-09-19 Impact factor: 2.655
Authors: Ans H Tiessen; Andries J Smit; Sebes Zevenhuizen; Edwin M Spithoven; Klaas Van der Meer Journal: BMC Fam Pract Date: 2012-12-10 Impact factor: 2.497